Dual kinin B1 and B2 receptor activation provides enhanced blood–brain barrier permeability and anticancer drug delivery into brain tumors

Further pharmacological evaluation of a novel synthetic peptide bradykinin B2 receptor agonist

(2013) Martin Savard et al.   BIOLOGICAL CHEMISTRY

The Blood-Brain Barrier: Its Influence in the Treatment of Brain Tumors Metastases

(2012) D. Fortin   CURRENT CANCER DRUG TARGETS

Induction of Selective Blood-Tumor Barrier Permeability and Macromolecular Transport by a Biostable Kinin B1 Receptor Agonist in a Glioma Rat Model

(2012) Jérôme Côté et al.   PLoS One

Selective tumor blood–brain barrier opening with the kinin B2 receptor agonist [Phe8ψ(CH2NH)Arg9]-BK in a F98 glioma rat model: An MRI study

(2010) Jérôme Côté et al.   NEUROPEPTIDES

Strategies to advance translational research into brain barriers

(2008) Edward Neuwelt et al.   LANCET NEUROLOGY

Structure–activity relationships of novel peptide agonists of the human bradykinin B2 receptor

(2008) Simon Bélanger et al.   PEPTIDES

Novel kinin B1 receptor agonists with improved pharmacological profiles

(2008) Jérôme Côté et al.   PEPTIDES